Trials / Completed
CompletedNCT01538212
Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Cerecin · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This evaluation of the efficacy and safety of AXONA will be a chart review carried out at 16 practices in which AXONA has been prescribed for the treatment of patients with mild-to-moderate AD. Efficacy of AXONA will be assessed by comparison of patient status before and after initiation of treatment.
Detailed description
The primary objective is to assess the efficacy of AXONA (medium chain triglycerides \[MCTs\]) when used alone or in combination with other agents in patients with mild-to-moderate Alzheimer's disease (AD) in routine clinical practice.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2012-02-24
- Last updated
- 2016-04-18
Source: ClinicalTrials.gov record NCT01538212. Inclusion in this directory is not an endorsement.